Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · C3B3E0001301014431
Magnesium Glycinate 400 mg 90 Capsules | Magnésium Bisglycinate | Énergie | Muscles | Sommeil
longtail
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
4
▼ 42.9% vs prev 4w
Offer Stock
5
Σ Stock across 1 live offer (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 221
avg of last 26 sells · latest 2026-09-24
C3B3E0001301014431
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 49 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate 400 mg 90 Capsules | Magnésium Bisglycinate | Énergie | Muscles | Sommeil · in the longtail cohort · last 4 weeks 4 units, trending down -42.9% · on-hand 6 units
Signals the model saw
- Cohort: longtail (238 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.60 — moderate
- Recent trend: last 4w = 4 units · prev 4w = 7 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 0.2 units |
| Realistic forecast — next 4 weeks | 0.5 units |
| Realistic forecast — next 3 months | 9.0 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 5.3 units |
| Optimistic — next week | 4.7 units |
| Optimistic — next 4 weeks (reorder target) | 17.3 units |
| Optimistic — next 3 months (quarterly PO target) | 49.5 units |
| Legacy μ/wk (reorder pipeline) | 1.0 |
| Revenue exposure — optimistic, 3 months | MAD 10.9K |